NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹7.22 Cr | ₹7.61 Cr | ₹10 Cr | ₹12 Cr | ₹9.44 Cr |
What is the latest Long Term Provisions ratio of NEULAND LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹7.22 Cr |
| Mar2024 | ₹7.61 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹9.44 Cr |
How is Long Term Provisions of NEULAND LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.22 Cr | -5.10 | |
| Mar2024 | ₹7.61 Cr | -26.05 | |
| Mar2023 | ₹10 Cr | -13.62 | |
| Mar2022 | ₹12 Cr | 26.22 | |
| Mar2021 | ₹9.44 Cr | - | |
Compare Long Term Provisions of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,087.3 Cr | -3.5% | -6.8% | 8.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -3.5% |
-6.8% |
8.8% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses